Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Dexamethasone | HCID 5743 | — |
| Reactant | 17beta-Hydroxy-16-methylenepregna-1,4,9(11)-triene-3,20-dione | HCID 13578837 | — |
| Product | Dexamethasone 9,11-epoxide | HCID 11143226 | — |
Reaction Steps
Dexamethasone (9α-fluoro-11β,17α,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione) can also be prepared from 17β-hydroxy-16-methylenepregna-1,4,9(11)-triene-3,20-dione (VIIB, Example 18) by first transforming it to 17α,21-dihydroxy-16-methylenepregna-1,4,9(11)-triene-3,20-dione 21-acetate (IX) as described above and next transforming it to 17α,21-dihydroxy-16α-methylpregna-1,4,9(11)-triene-3,20-dione 21-acetate (XI) by the process of U.S. Pat. No. 3,130,209. 17α,21-Dihydroxy-16α-methylpregna-1,4,9(11)-triene-3,20-dioine 21-acetate (XI) is then epoxidized by means well known to those skilled in the art, see for example U.S. Pat. No. 3,980,778 Examples 2 and 7 to produce 9β,11β-epoxy-17α,21-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione which is transformed to dexamethasone 21-acetate by the process of U.S. Pat. No. 3,007,923 Example 2.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04567001 |
|---|
| Source dataset | uspto-grants-1986_01 |
|---|
| ORD ID | ord-82c6899d60234582bdf3d1fbfa578039 |
|---|
| Source note | uspto-grants-1986_01 |
|---|